Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04717869 · ClinicalTrials.gov registry record
Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
A clinical trial of Frailty and Sarcopenia, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT04717869 is a study of Frailty and Sarcopenia that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 250 participants, below the 1,501-participant average among 48 other Frailty trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04717869, a study of Frailty and Sarcopenia, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
Frailty, the decline in physical and cognitive reserves leading to vulnerability to stressors is increasingly being recognized as a public health concern. Although multiple measures exist that can identify frail patients, very little is known about how or when to intervene. Sarcopenia, or the degree of muscle wasting, is closely correlated to frailty and patient outcomes. This is a prospective cohort study of critically ill patients to identify modifiable risk factors of sarcopenia, as potential targets to reduce frailty.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Ultrasound
- DIAGNOSTIC_TEST Biomarker Analysis
- OTHER Frailty Index
Study Locations (1)
California
- Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-09-22 |
| Est. Completion | 2026-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04717869
The ClinicalTrials.gov registry entry for NCT04717869 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,501-participant average among 48 other Frailty trials with a reported enrollment target (83% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Frailty appearing as the primary indexed condition, and to 3 interventions - of which Ultrasound is the first listed.
NCT04717869 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04717869 about?
NCT04717869 is a clinical study titled "Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty". Frailty, the decline in physical and cognitive reserves leading to vulnerability to stressors is increasingly being recognized as a public health concern. Although multiple measures exist that can identify frail patients, very little is known about how or when to intervene. Sarcopenia, or the degree...
What is the current status of trial NCT04717869?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2023-09-22. Estimated completion is 2026-07.
What conditions does trial NCT04717869 study?
This clinical trial studies the following conditions: Frailty, Sarcopenia.
What interventions are being tested in trial NCT04717869?
The interventions under investigation include: Ultrasound (DIAGNOSTIC_TEST), Biomarker Analysis (DIAGNOSTIC_TEST), Frailty Index (OTHER).
Who is sponsoring clinical trial NCT04717869?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04717869 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Frailty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Physical Ability and Cellular Senescence Elimination in HIV
RECRUITING · Phase 2
-
Reducing Frailty for Older Cancer Survivors Using Supplements II
RECRUITING · Phase 2
-
A Partnered Evaluation to Improve the Identification and Management of Functional Impairment and Frailty Among Older Veterans in Primary Care Settings
RECRUITING · NA
-
Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal Clients
RECRUITING · NA
-
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
RECRUITING · Phase 2
-
Evaluation of the Walk With Ease Program for Fall Prevention
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.